About
Silicone Vasculature
Areas of Focus
Categories
Surgical DeviceSan Diego & Southern California
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
9
As Collaborator
4
Total Enrollment
1,452
By Phase
PHASE1/PHASE2: 5PHASE1: 3PHASE3: 1PHASE2: 4
By Status
RECRUITING: 5COMPLETED: 5ACTIVE_NOT_RECRUITING: 1TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07136545Collaborator
A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
PHASE1/PHASE2Recruiting
50 participants
Started: Aug 1, 2025 · Completed: Dec 31, 2026
NCT07204574Collaborator
The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer
PHASE1/PHASE2Recruiting
40 participants
Started: May 14, 2025 · Completed: Dec 31, 2025
NCT06487624Lead Sponsor
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
PHASE1Recruiting
50 participants
Started: Apr 2, 2025 · Completed: Aug 31, 2026
NCT06771622Lead Sponsor
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
150 participants
Started: Mar 13, 2025 · Completed: Jan 1, 2029
NCT06510504Lead Sponsor
Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1
PHASE3Active, not recruiting
332 participants
Started: Aug 6, 2024 · Completed: Sep 30, 2025
Funding History (1)
D
Apr 29, 2013
Locations (1)
Headquarters
Irvine, CA, United States
Map
Loading map...